These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 1280716)
1. Contrasting effects of cyclic AMP increase caused by beta-adrenergic stimulation or by adenylate cyclase activation on ventricular fibrillation threshold of isolated rat heart. Worthington MG; Opie LH J Cardiovasc Pharmacol; 1992 Oct; 20(4):595-600. PubMed ID: 1280716 [TBL] [Abstract][Full Text] [Related]
2. Effect of interventions that increase cyclic AMP levels on susceptibility to ventricular fibrillation in unanesthetized dogs. Avendano CE; Billman GE Eur J Pharmacol; 1994 Apr; 255(1-3):99-109. PubMed ID: 7517886 [TBL] [Abstract][Full Text] [Related]
3. Influence of ischaemia and reperfusion on cardiac signal transduction. G protein content, adenylyl cyclase activity, cyclic AMP content, and forskolin and dibutyryl cyclic AMP-induced inotropy in the rat Langendorff heart. van den Ende R; Batink HD; Michel MC; van Zwieten PA Fundam Clin Pharmacol; 1994; 8(5):408-16. PubMed ID: 7875634 [TBL] [Abstract][Full Text] [Related]
4. Beta 1-adrenergic selectivity of the new cardiotonic agent denopamine in its stimulating effects on adenylate cyclase. Inamasu M; Totsuka T; Ikeo T; Nagao T; Takeyama S Biochem Pharmacol; 1987 Jun; 36(12):1947-54. PubMed ID: 3036156 [TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with carbachol sensitizes the myocardium to cAMP-induced arrhythmia. Eschenhagen T; Mende U; Diederich M; Hertle B; Memmesheimer C; Pohl A; Schmitz W; Scholz H; Steinfath M; Böhm M; Michel MC; Brodde OE; Raap A Circulation; 1996 Feb; 93(4):763-71. PubMed ID: 8641006 [TBL] [Abstract][Full Text] [Related]
7. 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart. Pepe S; Xiao RP; Hohl C; Altschuld R; Lakatta EG Circulation; 1997 Apr; 95(8):2122-9. PubMed ID: 9133523 [TBL] [Abstract][Full Text] [Related]
8. Effect of essential fatty acid deficiency on forskolin binding sites, adenylate cyclase and cyclic AMP-dependent protein kinase activity, the levels of G proteins and ventricular function in rat heart. Alam SQ; Mannino SJ; Alam BS; McDonough K J Mol Cell Cardiol; 1995 Aug; 27(8):1593-604. PubMed ID: 8523422 [TBL] [Abstract][Full Text] [Related]
9. Developmental changes in modulation of contractility of rabbit hearts. Akita T; Kumar R; Joyner RW J Cardiovasc Pharmacol; 1995 Feb; 25(2):240-51. PubMed ID: 7538615 [TBL] [Abstract][Full Text] [Related]
10. Effects of calcium channel agonism by Bay-K-8644 on ventricular fibrillation threshold of isolated heart. Worthington MG; Opie LH Cardiovasc Drugs Ther; 1992 Dec; 6(6):597-604. PubMed ID: 1284030 [TBL] [Abstract][Full Text] [Related]
11. Forskolin and myocardial function in the normal, ischemic and reperfused rat heart. Hearse DJ; Zucchi R; Buschmans E; Manning AS Can J Cardiol; 1986; 2(5):303-12. PubMed ID: 3021303 [TBL] [Abstract][Full Text] [Related]
12. Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism. Endoh M Basic Res Cardiol; 1989; 84 Suppl 1():69-83. PubMed ID: 2554874 [TBL] [Abstract][Full Text] [Related]
14. Cholinergic antagonism of beta-adrenergic stimulated action potentials and adenylate cyclase activity in rabbit ventricular cardiomyocytes. Watson JM; Vogel SM; Cotterell DJ; Dubocovich ML Eur J Pharmacol; 1988 Oct; 155(1-2):101-8. PubMed ID: 2468508 [TBL] [Abstract][Full Text] [Related]
15. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes. Litosch I; Hudson TH; Mills I; Li SY; Fain JN Mol Pharmacol; 1982 Jul; 22(1):109-15. PubMed ID: 6289066 [TBL] [Abstract][Full Text] [Related]
16. Effects of forskolin on inotropic performance and phospholamban phosphorylation in exercise-trained hypertensive myocardium. Kolwicz SC; Kubo H; MacDonnell SM; Houser SR; Libonati JR J Appl Physiol (1985); 2007 Feb; 102(2):628-33. PubMed ID: 17082376 [TBL] [Abstract][Full Text] [Related]
17. Evidence for different interactions between beta(1)- and beta(2)-adrenoceptor subtypes with adenylyl cyclase in the rat brain: a concentration-response study using forskolin. Morin D; Sapena R; Tillement JP; Urien S Pharmacol Res; 2000 Apr; 41(4):435-43. PubMed ID: 10704268 [TBL] [Abstract][Full Text] [Related]
18. Forskolin stimulates prostaglandin synthesis in rabbit heart by a mechanism that requires calcium and is independent of cyclic AMP. Williams JL; Malik KU Circ Res; 1990 Nov; 67(5):1247-56. PubMed ID: 2171806 [TBL] [Abstract][Full Text] [Related]
19. Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart. Tanaka H; Shigenobu K Br J Pharmacol; 1990 May; 100(1):138-42. PubMed ID: 2164856 [TBL] [Abstract][Full Text] [Related]
20. Cardiac inotropic responses to calcium and forskolin are not altered by prolonged isoproterenol infusion. Bowling N; Wyss VL; Gengo PJ; Utterback B; Kauffman RF; Hayes JS Eur J Pharmacol; 1990 Oct; 187(2):155-64. PubMed ID: 1703077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]